• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Friday, May 9
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

    May 9, 2025

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025

    Federal Reserve Holds Interest Rates Steady Despite Pressure From Trump

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Health»CDC advisers recommend seasonal use of Pfizer RSV shot
Health

CDC advisers recommend seasonal use of Pfizer RSV shot

September 22, 2023No Comments6 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
CDC advisers recommend seasonal use of Pfizer RSV shot
Share
Facebook Twitter LinkedIn Pinterest Email

Pfizer’s new shot to protect infants against respiratory syncytial virus by vaccinating their mothers late in pregnancy won a limited recommendation Friday from an expert panel that advises the Centers for Disease Control and Prevention, clearing the way for a second product to protect babies against RSV to soon hit the market.

The recommendation was accepted by CDC Director Mandy Cohen shortly after the conclusion of the panel’s meeting.

“This is another new tool we can use this fall and winter to help protect lives,” Cohen said in a statement. “I encourage parents to talk to their doctors about how to protect their little ones against serious RSV illness, using either a vaccine given during pregnancy, or an RSV immunization given to your baby after birth.”

The vote, which passed the Advisory Committee on Immunization Practices by an 11-to-1 margin, was an attempt to make the choice of preventive measures less complicated for parents-to-be and the obstetricians and pediatricians who will care for each mother-baby pair. The goal is to ensure babies are protected with one or the other anti-RSV product, but ideally not both together.

Using both in a mother-baby pair would offer little or no added benefit for most babies, and would come at a high cost, with Pfizer set to charge $295 for its vaccine and the other product, Sanofi’s monoclonal antibody, priced at $495. Insurance companies are unlikely to pay for both, unless there is a medical reason for giving a child born to a vaccinated mother the monoclonal antibody.

Pfizer publicly welcomed the development.

“Today’s ACIP recommendation for maternal immunization with Abrysvo reinforces the wide-ranging impact vaccines can have, including helping protect infants immediately at birth from the potentially severe and life-threatening complications that can develop from RSV,” said Luis Jodar, chief medical affairs officer for vaccines/antivirals and evidence generation.

See also  Democrat is forced to self-correct after alarming Freudian slip targeting Trump: 'Needs to be shot'

But the recommendation was not a clear victory for Pfizer, effectively limiting the time of the year in which use of the vaccine will be recommended.

The ACIP recommended “seasonal administration” of the company’s vaccine, meaning that its use should focus on pregnant people who would reach 32 to 36 weeks of gestation — the point when the vaccine can be given — during the period of September to January to protect babies born between October and March, when the risk of RSV infection is traditionally highest. The Pfizer vaccine would not be recommended for use in most of the continental U.S. from February to August.

In those months, Sanofi’s monoclonal antibody, Beyfortus, should be used to protect babies as they approach their first RSV season. Maternal antibodies would most likely have waned in those babies by the start of the RSV season if their mother had been vaccinated during pregnancy.

In some parts of the country — Alaska, parts of Florida, Hawaii, Puerto Rico, the U.S. Virgin Islands, and Guam — RSV can circulate year round. The seasonal rule for use of the vaccine would not apply in these areas.

Until this year, there have been no tools with which to prevent RSV, which causes enormous numbers of illnesses in young babies every year. Though the death toll in this country is not high, between 1.5 million children are taken for medical care for RSV every year, nearly half a million end up in an emergency room, and between 58,000 and 80,000 are hospitalized for these infections.

See also  FDA approves the first-ever RSV vaccine

RSV transmission typically peaks some time between November and late March, but since the start of the Covid-19 pandemic, the season has been somewhat erratic. Last year the RSV season began in the early autumn and peaked just after Thanksgiving.

Though the ACIP vote limits the time during which the vaccine should be used, it is not meant to indicate a preference for the vaccine over the monoclonal antibody during the time when the vaccine would be effective, CDC vaccine expert Jefferson Jones explained to the committee. Even in the September-to-January window, pregnant people will have the option of deciding whether they want to take the shot, or would prefer to wait to have their baby receive the monoclonal antibody, he said.

Discussions between parents-to-be and obstetricians will be critical, and there were concerns raised about whether this specialty has the time or the in-depth knowledge to help pregnant people make this choice.

“There needs to be massive education,” warned Helen “Keipp” Talbot, an infectious diseases expert from Vanderbilt University, who was the sole ACIP member to vote against recommending the vaccine.

Earlier in the day, Talbot questioned the value of approving the Pfizer vaccine, given the existence of the monoclonal antibody, which appears to protect for longer and, while more expensive, appears to be more cost-effective than the vaccine. “What’s the benefit of this vaccine? Why recommend it at all?” Talbot asked.

But other members of the committee warned of the risks of relying on a single product, and alluded to the possibility that supplies of Beyfortus may not be adequate to protect an entire birth cohort in the first year after the product hits the market.

See also  A common UTI test for kids haunts adults as a traumatic 'nightmare'

Figuring out how to rationally use these two competing products — each of which appears to be highly effective, but is accompanied by implementation challenges — has taken considerable time and discussion for CDC staff and the ACIP’s maternal and pediatric RSV work group.

But if Friday’s meeting is any indication, implementation of these tools will create challenges over the next year or two.

Some members of the ACIP questioned whether the wording of the vote meant that the Pfizer vaccine should be given preferentially to near-term pregnant people during the September-to-January window, effectively ruling out a parent’s choice to opt for the monoclonal antibody. Another member asked whether pregnant people who reached the 32-to-36 week mark of their pregnancy in February through August would be denied the right to get the vaccine.

Several members of the committee expressed deep disappointment about the cost of the vaccine, which the company had previously indicated might be sold for $200 a dose. “$295 is a hard number for me to swallow,” said Katherine Poehling, professor of pediatrics at Wake Forest School of Medicine, who nonetheless voted to recommend the vaccine.

Pablo Sanchez, a professor of pediatrics at Ohio State University, pressed Pfizer to disclose how much the company will charge for the maternal vaccine in Europe. Donna Altenpohl, vice president of market access strategy, sidestepped the question, saying pricing elsewhere has not been finalized.

advisers CDC Pfizer Recommend RSV seasonal shot
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Novak Djokovic Drills Winning Shot After Woke Heckler Tells Him to Get Vaxed

January 21, 2024

NASA Delays Moon Shot as Private U.S. Lander Looks Set to Fail

January 11, 2024

Michigan State’s Jeremy Fears Jr. Shot While Visiting Hometown

December 25, 2023

Spotify CEO ‘Should Be Taken Out and Shot’

December 23, 2023
Add A Comment

Leave A Reply Cancel Reply

Top Posts

Executives At Signature Bank Dumped $100 Million In Stock During Crypto Uptick

April 5, 2023

The Avène Spring Friends & Fam Sale Is Here—What To Shop

May 16, 2023

INSANITY: Biden Regime Proposes Ban on Sale of Portable Gas Generators, Raising Concerns for Power Outage Reliance | The Gateway Pundit

July 23, 2023

Car Thefts Soar By 19% In New York, Police Blame TikTok Challenge

September 7, 2023
Don't Miss

How Smart Mattresses Improve Sleep Quality For Couples

Lifestyle May 9, 2025

Sharing a bed with your partner can be romantic… until it’s not. One of you…

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025

Trump Announces First Post-Tariff Trade Deal

May 8, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,111)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,628)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

LA Knight will not be a WWE world champion in the next year, according to former writer (Exclusive)

June 17, 2023

Aerosmith Singer and Maui Homeowner Steven Tyler Urges Tourists to Return to the Island

September 5, 2023

Petition Urging Commanders to Bring Back ‘Redskins’ Name Surpasses 100,000 Signatures

August 16, 2023
Popular Posts

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025

Short and Funny Sayings for a Happy Summer with Friends

May 9, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.